Nitroglycerin Patch
Product Images NDC 0378-9104

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 0378-9104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nitroglycerin Structural Formula (Image 01)

Nitroglycerin Structural Formula (Image 01)
Chemical structure of nitroglycerin, displaying the arrangement of its molecular components with nitrogen, carbon, hydrogen, and oxygen atoms connected in a specific configuration.*
FDA Label Image

Patch Cross Section (Image 02)

Patch Cross Section (Image 02)
A cross-sectional diagram of a Nitroglycerin transdermal patch showing its layers. The patch includes an impermeable backing on top, a nitroglycerin/adhesive layer in the middle, and a peelable protective liner on the bottom.*
FDA Label Image

Patient Information Figure 01 (Image 03)

Patient Information Figure 01 (Image 03)
Nitroglycerin 1 mg/h transdermal patch. The image shows a rectangular patch with rounded edges, featuring the text 'Nitroglycerin 1 mg/h' printed on the adhesive side. The patch includes a horizontal line marker near the right side.*
FDA Label Image

Patient Information Figure 02 (Image 04)

Patient Information Figure 02 (Image 04)
An instructional illustration showing two hands peeling open a square packet containing a patch, demonstrating how to remove the nitroglycerin transdermal patch from its packaging.*
FDA Label Image

Patient Information Figure 03 (Image 05)

Patient Information Figure 03 (Image 05)
An instructional illustration showing two hands peeling apart the protective backing from a Nitroglycerin transdermal patch. The image demonstrates how to separate the patch from its sealed liner before application to the skin.*
FDA Label Image

Patient Information Figure 04 (Image 06)

Patient Information Figure 04 (Image 06)
An instructional line drawing showing a person applying a transdermal patch to the chest area. The illustration depicts hands placing a square patch centrally on an upper torso, demonstrating the application process for a Nitroglycerin transdermal patch.*
FDA Label Image

Patient Information Figure 05 (Image 07)

Patient Information Figure 05 (Image 07)
An instructional illustration showing the application of a nitroglycerin transdermal patch. The image depicts a person placing the rectangular patch on the upper chest area, demonstrating how to apply the medication on the skin.*
FDA Label Image

Nitroglycerin Transdermal System 0.1 mg/hr Carton (Image 08)

Nitroglycerin Transdermal System 0.1 mg/hr Carton (Image 08)
Packaging label for Nitroglycerin Transdermal System 0.1 mg/hr patches by Mylan Pharmaceuticals Inc. The label indicates this is a box containing 30 transdermal patches. It features dosage strength, usage instructions, a barcode, and the Mylan logo on a predominantly blue and white background.*
FDA Label Image

Nitroglycerin Transdermal System 0.2 mg/hr Carton (Image 09)

Nitroglycerin Transdermal System 0.2 mg/hr Carton (Image 09)
Nitroglycerin 0.2 mg/hr transdermal system patch packaging from Mylan Pharmaceuticals Inc. The label highlights that each 8 cm² system contains 22.4 mg of nitroglycerin with a rated release of 0.2 mg/hr. The carton holds 30 systems and includes application instructions and NDC number 0378-9104-93.*
FDA Label Image

Nitroglycerin Transdermal System 0.4 mg/hr Carton (Image 10)

Nitroglycerin Transdermal System 0.4 mg/hr Carton (Image 10)
Packaging label for Nitroglycerin Transdermal System 0.4 mg/hr patch by Mylan Pharmaceuticals Inc. The label shows a box containing 30 systems, with detailed product information, instructions for application, and identification markings including NDC 0378-9112-93. The patch is indicated for transdermal use only.*
FDA Label Image

Nitroglycerin Transdermal System 0.6 mg/hr Carton (Image 11)

Nitroglycerin Transdermal System 0.6 mg/hr Carton (Image 11)
Nitroglycerin Transdermal System 0.6 mg/hr patch carton from Mylan Pharmaceuticals Inc. The label shows a 30-system package. It includes usage instructions, dosage strength, active ingredient quantity per system (67.2 mg), and storage conditions. The packaging is primarily blue and white with the Mylan logo and an NDC barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.